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Material and Methods: A rat model was used to investigate a 
possible selective accumulation of circulating lymphocites to 
specific anatomical districts after radiation treatment 
focused to the urinary bladder. Eight Fisher rats were 
adoptively transferred with 4x107 VivoTag-750-labelled 
syngeneic primary splenocytes at two hours before the 
bladder irradiation. Two of eight rats were used as controls. 
Animals were transurethrally catheterized to allow contrast 
agent instillation. A kV cone beam computed tomography 
(CBCT) was acquired for each rat, to precisely deliver 6 MeV 
monofraction photon field. Rats were divided into three 
groups (n=2/group) receiving different levels of dose: 15, 20 
and 25 Gy. A bolus thickness equal to 1cm was positioned on 
the rat skin surface in the pelvic region. Ultrasound images of 
the pelvic region were acquired at baseline, at 2, 4 and 6 
days after irradiation to monitor thickness variations of the 
bladder wall tissue. In vivo fluorescent imaging was used to 
evaluated accumulation sites of labelled leukocytes. 
 
Results: A significant increase in the bladder wall thickness 
was found 4 days after irradiation in animals treated with a 
dose equal to 25 Gy. A fluorescent signal, secondary to 
labelled splenocytes accumulation, emerged in the liver and 
lymph nodes of all adoptively transferred rats, 2 and 6 days 
after irradiation, as expected. A modest specific signal (30% 
increase) at the bladder level resulted only in two animals 
receiving the higher dose (Figure 1.a), when compared to the 
non-irradiated (Figure 1.b). No specific fluorescent signal was 





Conclusion: The relocalization of peripheral leukocytes in 
the damaged tissue depends on the radiation dosage and it 
may be evaluated by means of a non-invasive imaging 
technique. Further analyses are currently ongoing. 
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Purpose or Objective: Lung cancer is one of the most 
frequent and deadly types of cancer in Europe. Several 
aspects of non-small cell lung cancer (nsclc) in men and 
women continue to indicate potential male-female 
differences. Among these, higher treatment responses to 
current therapies in women are supposed, since women have 
better prognosis in any stage of the disease. In most stages of 
nsclc cytotoxic anti-cancer therapy (radiotherapy, 
chemotherapy) is used. It is known that treatment efficacy of 
cytotoxic anti-cancer therapy depends on tumor DNA-repair. 
Therefore, the aim of this study was to evaluate gender 
differences in the expression of DNA repair enzyme DNA 
protein kinase (DNA-PK). 
Material and Methods: Surgically excised nsclc tissues 
(n=111, 50 adenocarcinomas, 61 squamous cell carcinomas) 
were examined for DNA-PK expression. After 
immunohistochemistry, the staining intensity of DNA-PK was 
quantified using an arbitrary score ranging from 0 (no 
staining) to 3 (strong signal). Also, the proportion (%) of DNA-
PK positive (DNA-PK+) tumor cells was determined. All 
parameters were examined by 2 independent researchers in 
10 randomly chosen microscopic fields (magnification x40). 
 
Results: Immunohistochemical parameters were examined by 
2 independent researchers whose results were in good 
accordance (p<0.0005). Staining intensities of DNA-PK and 
the proportion of DNA-PK+ tumor cells varied, being in the 
whole nsclc group 2.4±0.4 (mean±SD) and 86.3±9.1% 
respectively. There were no significant gender differences in 
adenocarcinoma. However, we detected significant 
differences among nsclc patients with squamous cell 
carcinoma. Both, DNA-PK staining intensity and the 
proportion of DNA-PK+ tumor cells were significantly higher 
in men than in women, 2.5±0.3 and 86.3±8.8% vs 2.1±0.6 and 
79.6±11.9% respectively (DNA-PK intensity: p<0.01; DNA-PK+ 
proportion: p=0,03). Additionally, we found that in squamous 
cell carcinoma, the expression of DNA-PK depends on smoking 
and pack-years. There was a correlation between pack-years 
and DNA-PK intensity (p=0.04), as well as between pack-years 
and the proportion of DNA-PK+ tumor cells (p=0.04). 
 
Conclusion: Expression of DNA-PK in squamous cell lung 
cancer has gender differences and depends on smoking. 
Significantly lower expression of tumor DNA-PK was found in 
women with this histological subtype of nsclc. Latter might 
be one of the reasons why cytotoxic anti-cancer therapy is 
more efficacious in women than in men. In further studies, 
the combination of DNA repair inhibitors and cytotoxic anti-
cancer therapy should be tested. 
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